greeksoup/ stock research
Stock research / United States / GILD / FY2007

Gilead Sciences (GILD) FY2007 results: revenue $4.2 billion

Gilead Sciences, Inc. (GILD) reported revenue of $4.2 billion for fiscal 2007, the year ended 31 December 2007. Net income was $1.6 billion, and diluted earnings per share $0.82. The figures are the company's own, from the 10-K it filed with the SEC on 1 March 2010.

Revenue
$4.2 billion
FY2007FY2007
Operating margin
51.2%
FY2007FY2007
Net income
$1.6 billion
FY2007FY2007
Diluted EPS
$0.82
FY2007FY2007

this yearthe year beforeHover a bar for its figure.

The year in brief

Income statement (profit and loss)

$ millionFY2007Last 8 years
Revenue4,230
Cost of revenue769
Gross profit3,461
Gross margin81.8%
Research and development591
Selling, general and administrative706
Operating income2,165
Operating margin51.2%
Interest expense63.2
Pre-tax income2,211
Income tax635
Effective tax rate28.7%
Net income1,585
Net margin37.5%
Diluted EPS$0.82
$ million except per share.
Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow

$ millionFY2007Last 8 years
Operating cash flow1,669
Capital expenditure78.6
Free cash flow1,590
Free cash flow margin37.6%
Cash from investing-1,302
Cash from financing-171
Share-based compensation185
Buybacks488
Diluted shares, weighted1,929m

Balance sheet

$ millionFY2007Last 8 years
Shareholders' equity3,753
Cash and equivalents968

10-K for the year ended 31 December 2007, filed 1 March 2010: the filing.